Skip to main content
. 2017 Dec 18;15(4):1036. doi: 10.18549/PharmPract.2017.04.1036

Table 2. Quality evaluation of systematic reviews according to R-AMSTAR.

Author, year 1 2 3 4 5 6 7 8 9 10 11 Total score
Bright, 2012 3 2 3 2 2 4 4 2 3 2 3 30
Carling, 2013 3 3 4 3 4 4 2 3 NA 1 4 31
Chaudhry, 2006 2 3 3 1 2 3 1 2 NA 1 3 21
Durieux, 2008 4 3 4 2 4 4 1 2 NA 1 3 26
Eslami, 2007 3 3 3 1 2 1 1 1 NA 1 1 17
Fathima, 2014 3 3 4 2 3 4 2 2 NA 2 3 28
Fraccaro, 2015 3 1 4 3 1 3 1 1 NA 2 3 26
Garg, 2005 3 3 3 1 1 2 2 4 NA 1 3 23
Georgiou, 2013 3 3 4 2 2 2 1 1 NA 2 3 23
Gillaizeau, 2013 3 4 4 3 4 4 4 4 4 2 2 38
Hemens, 2011 4 3 2 1 2 4 2 1 NA 2 3 24
Heselmans, 2009 3 3 4 2 4 4 1 4 NA 1 3 29
Holstiege, 2015 2 3 4 3 4 4 2 2 NA 2 3 29
Hunt, 1998 2 3 3 3 1 2 2 2 NA 1 2 21
Jamal, 2009 3 1 4 3 1 2 2 4 NA 1 1 22
Jeffery, 2013 4 4 3 1 1 4 2 2 2 1 4 28
Lainer, 2013 3 3 4 3 2 4 1 1 NA 1 3 25
Lobach, 2012 3 4 4 2 4 4 3 3 4 4 3 38
Marasinghe, 2015 3 1 3 1 0 2 3 2 NA 2 3 20
Marc, 2013 1 1 2 1 0 1 1 1 NA 1 1 10
Millery, 2010 3 3 4 1 1 4 1 1 NA 2 3 23
Montgomery, 1998 3 1 3 3 1 4 1 1 NA 1 3 21
Nieuwlaat, 2011 3 3 3 1 2 4 2 2 4 1 3 28
Njie, 2015 2 3 1 1 0 3 2 4 NA 2 3 21
Oluoch, 2012 3 3 4 2 2 4 1 2 NA 1 2 24
O’Reilly, 2012 2 2 3 3 0 3 1 1 NA 1 3 19
Pearson, 2009 3 3 4 2 2 4 2 2 NA 1 3 26
Randell, 2007 3 3 3 4 1 2 2 1 NA 1 1 21
Robertson, 2010 3 4 4 2 2 4 3 2 NA 1 3 28
Roshanov, 2011 (1) 4 4 4 3 2 4 2 2 NA 2 3 30
Roshanov, 2011 (2) 3 3 3 1 2 4 2 2 NA 2 3 25
Sahota, 2011 3 3 3 3 2 4 3 2 NA 2 3 28
Schedlbauer, 2009 3 3 3 3 2 1 2 1 NA 1 1 20
Shebl, 2007 2 1 3 3 1 4 1 1 NA 1 3 20
Shojania, 2009 3 3 3 4 2 2 1 1 1 1 3 24
Shojania, 2010 3 3 3 4 2 2 1 1 1 1 3 24
Sintchenko, 2007 3 1 3 2 1 4 1 1 NA 2 1 19
Souza, 2011 3 3 3 3 2 4 2 2 NA 2 3 27
Sturzlinger, 2009 2 1 3 2 1 1 1 1 NA 1 1 14
Tawadrous, 2011 3 4 3 4 2 4 2 1 NA 1 3 27
Vedel, 2013 3 3 3 3 0 2 2 1 NA 2 2 22
Welch, 2013 2 2 3 2 2 4 1 1 NA 2 3 22
Wong, 2010 3 3 3 2 2 4 2 2 4 2 2 29
Yourman, 2008 3 3 4 1 2 4 1 1 NA 2 1 22

NA: not applicable